The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
A look at new legal battles and drug regulations, including the administration's new initiatives to reduce drug costs and next steps in the FTC's attempt to address improperly listed patents in the FDA's Orange Book.